Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LIFECORE BIOMEDICAL, INC. \DE\ Director's Dealing 2012

Mar 28, 2012

33431_dirs_2012-03-28_b0938cb6-5974-4f94-9c52-1992446ac8e1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LANDEC CORP \CA\ (LNDC)
CIK: 0001005286
Period of Report: 2012-03-26

Reporting Person: Midyett Ronald Lane (Executive Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-03-26 Common Stock M 150000 $6.13 Acquired 159665 Direct
2012-03-26 Common Stock M 138350 $7 Disposed 21315 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-03-26 NonQualified Stock Option $6.13 X 150000 Acquired 2012-05-19 Common Stock (150000) Direct

Footnotes

F1: Mr Midyett surrendered to the Issuer the right to receive an aggregate of 138,350 shares of Common Stock. Mr Midyett did not sell any shares of Common Stock in connection with the foregoing exercise.